An Update on the Management of Rectal Neuroendocrine Neoplasms
Current Treatment Options in Oncology · 2024-11 · 25 (11) · 1461-1470
DOI: 10.1007/s11864-024-01267-4 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Current Treatment Options in Oncology, online erschienen am 30.10.2024. Verfasst von Aviva Frydman und 1 weiteren Autor:innen. Beteiligte Einrichtung: Neuroendocrine Tumour Unit, King's College Hospital, London, UK. Hauptthemen laut MEDLINE: Rectal Neoplasms, Neuroendocrine Tumors, Disease Management. Die Arbeit wurde bisher 18-mal zitiert (Crossref) und nennt 46 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Opinion Statement Rectal neuroendocrine neoplasms (NENs) are increasing in incidence. Most lesions are low grade, well-differentiated neuroendocrine tumours with good long term outcomes. However there is metastatic potential and resection offers the only option for a cure and in most cases should be offered to reduce the risk of metastases. Careful staging of rectal NENs should be performed prior to consideration of resection in order to ensure the appropriate technique is chosen, and reduce the risk of incomplete resection. Resection can be endoscopic or surgical, and selecting the appropriate resection technique relies on tumour characteristics such as size, grade, invasion into the muscularis propria, presence of lymph node involvement or of distal metastases. Some patients may require systemic therapies which may involve somatostatin analogues (SSAs), everolimus, tyrosine kinase inhibitors (TKIs), chemotherapy or peptide receptor radionuclide therapy (PRRT). Due the rarity of these tumours, much of the evidence is based on retrospective reviews or smaller cohort studies. This article is an update of the current evidence available to guide management.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Neuroendocrine Tumour Unit, King's College Hospital, London, UK.
- Neuroendocrine Tumour Unit, King's College Hospital, London, UK. r.srirajaskanthan@nhs.net.
- Department of Gastroenterology, Kings College Hospital, 2Nd Floor Hambleden Wing, Denmark Hill, London, SE5 9RS, UK. r.srirajaskanthan@nhs.net.
Zitieren
APA
Frydman, A., & Srirajaskanthan, R. (2024). An Update on the Management of Rectal Neuroendocrine Neoplasms. Current Treatment Options in Oncology, 25(11), 1461-1470. https://doi.org/10.1007/s11864-024-01267-4
Vancouver
Frydman A, Srirajaskanthan R. An Update on the Management of Rectal Neuroendocrine Neoplasms. Current Treatment Options in Oncology. 2024;25(11):1461-1470. doi:10.1007/s11864-024-01267-4
BibTeX
@article{Frydman2024,
author = {Frydman, Aviva and Srirajaskanthan, Raj},
title = {An Update on the Management of Rectal Neuroendocrine Neoplasms},
journal = {Current Treatment Options in Oncology},
year = {2024},
volume = {25},
number = {11},
pages = {1461--1470},
doi = {10.1007/s11864-024-01267-4}
}
EUVIMED